Literature DB >> 23978138

Structural and mechanistic bases of the anticancer activity of natural aporphinoid alkaloids.

Yanjuan Liu1, Junxi Liu, Duolong Di, Min Li, Yan Fen.   

Abstract

Aporphinoid alkaloids, which encompass a large number of complicated structures, are an important group of natural products. The anticancer activity of aporphinoid alkaloids has become a hot pharmaceutical research area in recent years. Recent studies on the anticancer activity of these compounds are reviewed. The structure activity relationships (SARs) and anticancer mechanisms of aporphinoid alkaloids, as well as simple aporphine, oxoaporphine, dehydroaporphine and dimeric aporphine, have been summarized. The presence of a 1,2-methylenedioxy group and methylation of nitrogen are key features to the cytotoxicity of aporphinoid alkaloids. Oxidation and dehydrogenation of C7 could improve the anticancer activity. The contributions of chirality of hydrogen at C6a and the substitution pattern of other positions about aporphinoid alkaloids for anticancer activity remain unknown. Induced cancer cells apoptosis, prevention of cell proliferation, DNA topoisomerase inhibition, reducing the drug-resistant cellular side population (SP) or cancer stem cells (CSCs) and inhibition of epidermal growth factor receptor (EGFR) tyrosine kinase seem to play important roles in the molecular mechanisms of anticancer activity about aporphinoid alkaloids.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23978138     DOI: 10.2174/15680266113139990147

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  8 in total

1.  Assessment of the cytotoxic effects of aporphine prototypes on head and neck cancer cells.

Authors:  Dorival Mendes Rodrigues-Junior; Nicolie Melanie de Almeida Pontes; Gabriela Estrela de Albuquerque; Viviane Carlin; Givago Prado Perecim; Cristiano Raminelli; André Luiz Vettore
Journal:  Invest New Drugs       Date:  2019-05-17       Impact factor: 3.850

Review 2.  Screening of promising chemotherapeutic candidates from plants extracts.

Authors:  Junei Kinjo; Daisuke Nakano; Toshihiro Fujioka; Hikaru Okabe
Journal:  J Nat Med       Date:  2016-04-16       Impact factor: 2.343

3.  Xylopine Induces Oxidative Stress and Causes G2/M Phase Arrest, Triggering Caspase-Mediated Apoptosis by p53-Independent Pathway in HCT116 Cells.

Authors:  Luciano de Souza Santos; Valdenizia Rodrigues Silva; Leociley Rocha Alencar Menezes; Milena Botelho Pereira Soares; Emmanoel Vilaça Costa; Daniel Pereira Bezerra
Journal:  Oxid Med Cell Longev       Date:  2017-12-06       Impact factor: 6.543

4.  Isocorydine derivatives and their anticancer activities.

Authors:  Mei Zhong; Yanjuan Liu; Junxi Liu; Duolong Di; Mengrou Xu; Yaya Yang; Wenguang Li; Yali Chen; Jinxia Liu
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

5.  Alkaloid and acetogenin-rich fraction from Annona crassiflora fruit peel inhibits proliferation and migration of human liver cancer HepG2 cells.

Authors:  Allisson B Justino; Rodrigo M Florentino; Andressa França; Antonio C M L Filho; Rodrigo R Franco; André L Saraiva; Matheus C Fonseca; Maria F Leite; Foued Salmen Espindola
Journal:  PLoS One       Date:  2021-07-08       Impact factor: 3.240

6.  Effects of 8-Amino-Isocorydine, a Derivative of Isocorydine, on Gastric Carcinoma Cell Proliferation and Apoptosis.

Authors:  Lei Song; Fei Zhao; Yong Liu; Xiaonong Guo; Chengli Wu; Junxi Liu
Journal:  Curr Ther Res Clin Exp       Date:  2021-03-04

7.  Study on pharmacokinetics and tissue distribution of the isocorydine derivative (AICD) in rats by HPLC-DAD method.

Authors:  Yali Chen; Qian Yan; Mei Zhong; Quanyi Zhao; Junxi Liu; Duolong Di; Jinxia Liu
Journal:  Acta Pharm Sin B       Date:  2015-04-16       Impact factor: 11.413

8.  Cytotoxicity of Aporphine, Protoberberine, and Protopine Alkaloids from Dicranostigma leptopodum (Maxim.) Fedde.

Authors:  Ruiqi Sun; Haiyan Jiang; Wenjuan Zhang; Kai Yang; Chengfang Wang; Li Fan; Qing He; Jiangbin Feng; Shushan Du; Zhiwei Deng; Zhufeng Geng
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-21       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.